Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer

Clinical trial NCT00017303 · UNKNOWN

Trial details

NCT number: NCT00017303
Sponsor: Cytran
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 2001-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.